Cabot Small Cap Confidential 235

THE BIG IDEA Let’s talk proteins. Proteins are the large, complex molecules that do the lion’s share of the work in your cells and are essential for all living organisms. They’re made up of hundreds of thousands of amino acids, smaller units that are attached long,...
Read More

Cabot Growth Investor 1408

Sellers Still Lurking The first three and a half weeks of October were brutal, with the S&P 500 (down 11%) and Nasdaq (down 14%) cascading significantly, turning both our Cabot Tides and Cabot Trend Lines bearish as we raised a boatload of cash. But those...
Read More

Cabot Growth Investor 1407

Over the Falls During the past few weeks, we’ve seen huge up days, crushing down days, dramatic reversals (like today’s), big earnings gaps (up and down) and a slew of big-font headlines ranging from U.S.-China trade rumors, views from Fed members concerning rate hikes, resignations...
Read More

Cabot Growth Investor 1406

Positive Action, but Need to See More After a hellacious October that saw many indexes, sectors and stocks crash over a three-week period, the past week and half has been a welcome relief. With today’s solid post-election rally, the S&P 500 and Nasdaq have about...
Read More

Cabot Small Cap Confidential 234

THE BIG IDEA A lot of attention is given to the companies that develop blockbuster drugs. Far less attention is paid to those that make the sophisticated manufacturing equipment that allow drugs to be developed, made for clinical trials, then produced at scale when approved. These...
Read More

Cabot Growth Investor 1405

Trends are Down Until Proven Otherwise When volatility picks up in the market, often after a sharp decline, investors are bombarded with predictions, many of them dramatically bullish (this is the buying opportunity of the century!) or bearish (another global financial crisis has begun!), in...
Read More

Cabot Growth Investor 1404

Downpours September was definitely a month of yellow flags—we saw lots of rotation out of growth stocks, two severe bouts of selling in leaders, and lots of sloppy, volatile action, which often signifies distribution after a long run. As we wrote in our last there...
Read More

Cabot Small Cap Confidential 233

THE BIG IDEA Read slowly. This will take some time to digest. We are on the verge of a renaissance in the industrial manufacturing industry that will forever change how products are designed, built and introduced to market. This renaissance is being driven by the same that...
Read More

Cabot Growth Investor 1403

Gusts of Wind, but No Rain Yet At the end of August, there were a lot of growth stocks (and growth-oriented indexes) extended to the upside, some near-term sentiment measures were a bit giddy and we were heading into September, a month that frequently its...
Read More

Cabot Growth Investor 1402

Many Potholes, but Growth Stocks Holding Every morning (after the kids’ lunches are done of course), I like to open up my laptop and take an unbiased look at the whole market—not just the growth stocks I recommend and follow, but various sector ETFs, measures...
Read More

Cabot Growth Investor 1401

Sellers Look Worn Out From mid June through mid August, the market was choppy, narrow, news-driven and rotational—not a great environment for making money, and in fact, we got knocked out of a few stocks as they cracked support, often following earnings reports. And two-month...
Read More

Cabot Growth Investor 1400

Positive, not Powerful When it comes to investing we’re big on rules. That’s because, if you invest solely by emotions and gut instinct, you’re bound to lose your way. That’s why we write about our key market timing indicators in every issue, and why have...
Read More

Cabot Growth Investor 1399

Growth Stocks Hit, Bull Market Fine For most stocks, 2018 has been a slog, with financials, industrials, consumer staples, transports and other areas doing much more chopping than trending. Growth stocks, though, have been winners—growth-oriented indexes like the Nasdaq and S&P 600 SmallCap have very...
Read More

Cabot Growth Investor 1398

Not Perfect, But Pretty Good Just about every morning when we check the financial media’s scuttlebutt, about 80% of the news is negative. Many of these are fundamental—the trade war, the Fed’s rate hike path and unwinding of its balance sheet—though some concern the itself,...
Read More

Cabot Growth Investor 1397

Still More Good than Bad When you get down to it, the market is an odds game. No matter what anyone tells you, nobody can know for sure where stocks are headed, which is why the best investors are like detectives—collecting and analyzing the to...
Read More

Cabot Benjamin Graham Enterprising 278E

Benjamin Graham is called The Father of Value Investing. His influence has inspired many successful investors, including Warren Buffett. O Canada! The U.S. stock market has been overvalued for quite some time. Canadian stocks, on the other hand, have been selling at very reasonable prices, the...
Read More